Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine
Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. Although the exact pathogenesis of PR is unknown, current evidence suggests that an inflammatory reaction due to a viral...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-11-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1963173 |
| _version_ | 1797673229665435648 |
|---|---|
| author | Olivia G. Cohen Ashley K. Clark Heather Milbar Mordechai Tarlow |
| author_facet | Olivia G. Cohen Ashley K. Clark Heather Milbar Mordechai Tarlow |
| author_sort | Olivia G. Cohen |
| collection | DOAJ |
| description | Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. Although the exact pathogenesis of PR is unknown, current evidence suggests that an inflammatory reaction due to a viral trigger may lead to the cutaneous manifestations. COVID-19 has been reported as one such viral trigger for PR. Previously, PR has been reported in temporal association with various viral inoculations. This article presents a case of PR in a 66-year-old black male 1 week after administration of the Pfizer-BioNTech COVID-19 vaccine. |
| first_indexed | 2024-03-11T21:41:29Z |
| format | Article |
| id | doaj.art-38889ae87855447db0512d690c86ec1d |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:41:29Z |
| publishDate | 2021-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-38889ae87855447db0512d690c86ec1d2023-09-26T12:59:14ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-11-0117114097409810.1080/21645515.2021.19631731963173Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccineOlivia G. Cohen0Ashley K. Clark1Heather Milbar2Mordechai Tarlow3The University of PennsylvaniaThe University of PennsylvaniaThe University of PennsylvaniaAdvanced Dermatology & Skin Surgery, PCPityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. Although the exact pathogenesis of PR is unknown, current evidence suggests that an inflammatory reaction due to a viral trigger may lead to the cutaneous manifestations. COVID-19 has been reported as one such viral trigger for PR. Previously, PR has been reported in temporal association with various viral inoculations. This article presents a case of PR in a 66-year-old black male 1 week after administration of the Pfizer-BioNTech COVID-19 vaccine.http://dx.doi.org/10.1080/21645515.2021.1963173vaccinationcovid-19pityriasis rosea |
| spellingShingle | Olivia G. Cohen Ashley K. Clark Heather Milbar Mordechai Tarlow Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine Human Vaccines & Immunotherapeutics vaccination covid-19 pityriasis rosea |
| title | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine |
| title_full | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine |
| title_fullStr | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine |
| title_full_unstemmed | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine |
| title_short | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine |
| title_sort | pityriasis rosea after administration of pfizer biontech covid 19 vaccine |
| topic | vaccination covid-19 pityriasis rosea |
| url | http://dx.doi.org/10.1080/21645515.2021.1963173 |
| work_keys_str_mv | AT oliviagcohen pityriasisroseaafteradministrationofpfizerbiontechcovid19vaccine AT ashleykclark pityriasisroseaafteradministrationofpfizerbiontechcovid19vaccine AT heathermilbar pityriasisroseaafteradministrationofpfizerbiontechcovid19vaccine AT mordechaitarlow pityriasisroseaafteradministrationofpfizerbiontechcovid19vaccine |